Sciclone Pharma (SCLN) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Join SI Premium – FREE
Sciclone Pharma (NASDAQ: SCLN) reported Q2 EPS of $0.26, $0.14 better than the analyst estimate of $0.12. Revenue for the quarter came in at $37.9 million versus the consensus estimate of $37.27 million.
For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Hilltop Holdings (HTH) Tops Q1 EPS by 17c
- First Financial (FFIN) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
